Follow
Jorge A. Alfaro-Murillo
Jorge A. Alfaro-Murillo
Verified email at yale.edu - Homepage
Title
Cited by
Cited by
Year
Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis
JA Lewnard, MLN Mbah, JA Alfaro-Murillo, FL Altice, L Bawo, ...
The Lancet Infectious Diseases 14 (12), 1189-1195, 2014
2402014
A cost-effectiveness tool for informing policies on Zika virus control
JA Alfaro-Murillo, AS Parpia, MC Fitzpatrick, JA Tamagnan, J Medlock, ...
PLoS neglected tropical diseases 10 (5), e0004743, 2016
952016
The potential economic burden of Zika in the continental United States
BY Lee, JA Alfaro-Murillo, AS Parpia, L Asti, PT Wedlock, PJ Hotez, ...
PLoS neglected tropical diseases 11 (4), e0005531, 2017
782017
Future epidemiological and economic impacts of universal influenza vaccines
P Sah, JA Alfaro-Murillo, MC Fitzpatrick, KM Neuzil, LA Meyers, BH Singer, ...
Proceedings of the National Academy of Sciences 116 (41), 20786-20792, 2019
372019
The case for replacing live oral polio vaccine with inactivated vaccine in the Americas
JA Alfaro-Murillo, ML Ávila-Agüero, MC Fitzpatrick, CJ Crystal, ...
The Lancet 395 (10230), 1163-1166, 2020
232020
Plant toxins and trophic cascades alter fire regime and succession on a boreal forest landscape
Z Feng, JA Alfaro-Murillo, DL DeAngelis, J Schmidt, M Barga, Y Zheng, ...
Ecological modelling 244, 79-92, 2012
142012
Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US
JA Alfaro-Murillo, JP Townsend, AP Galvani
Vaccine 34 (2), 225-229, 2016
112016
A deterministic model for influenza infection with multiple strains and antigenic drift
JA Alfaro-Murillo, S Towers, Z Feng
Journal of Biological Dynamics, 2013
102013
Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics
PV Prasad, MK Steele, C Reed, LA Meyers, Z Du, R Pasco, ...
Proceedings of the National Academy of Sciences 120 (28), e2300590120, 2023
32023
Heavy mutagenesis by tobacco leads to lung adenocarcinoma tumors with KRAS G12 mutations other than G12D, leading KRAS G12D tumors—on average—to exhibit a lower mutation burden
C Tan, JD Mandell, K Dasari, VL Cannataro, JA Alfaro-Murillo, ...
Lung Cancer 166, 265-269, 2022
32022
Analysis of an epidemiological model structured by time-since-last-infection
JA Alfaro-Murillo, Z Feng, JW Glasser
Journal of Differential Equations 267 (10), 5631-5661, 2019
32019
An epidemic model structured by the time since last infection
JA Alfaro-Murillo
Purdue University, 2013
22013
Tobacco smoke alters the adaptive landscape of lung adenocarcinoma and influences the strength of epistatic interactions
K Dasari, J Alfaro-Murillo, J Townsend
Cancer Research 84 (6_Supplement), 1251-1251, 2024
2024
Abstract IA014: Detecting epistatic effects among somatic cancer mutations across oncogenesis
JA Alfaro-Murillo, K Dasari, JP Townsend
Cancer Research 84 (3_Supplement_2), IA014-IA014, 2024
2024
Pairwise and higher-order epistatic effects among somatic cancer mutations across oncogenesis
JA Alfaro-Murillo, JP Townsend
Mathematical Biosciences 366, 109091, 2023
2023
Pairwise and higher-order epistatic effects among somatic cancer mutations across oncogenesis of lung adenocarcinoma
JA Alfaro-Murillo, K Dasari, JP Townsend
Cancer Research 83 (7_Supplement), 862-862, 2023
2023
An Agent-Based Model with Drift and Cross-Immunity for Influenza
JA Alfaro-Murillo
The system can't perform the operation now. Try again later.
Articles 1–17